Résultats de la recherche
Les résultats s’affichent automatiquement selon le filtre sélectionné.
629 résultat(s) trouvé(s)
Remarque : Le présent document n’est pas une politique. Il s’agit de renseignements supplémentaires illustrant la façon dont la Commission de la sécurité professionnelle et…
Remarque : Le présent document n’est pas une politique. Il s’agit d’un document supplémentaire illustrant la façon dont la Commission de la sécurité professionnelle et…
sur cette page : Principes clés Introduction Collecte de preuves pertinentes…
Sur cette page : Principes clés Définitions Introduction …
La WSIB crée des documents de pratiques administratives lorsqu'elle détermine qu'un document supplémentaire est nécessaire pour aider à comprendre l'application pratique de…
Documents généraux : Documents d’audit – Rapports finaux Documents d’audit – Documents de travail Gestion des audits
AudioVisuelUne musique de fond entraînante et inspirante joue.Logo de la WSIBAmirah dit : L’innovation est très importante à la WSIB.Amirah s’adresse à une personne…
Indication(s)The treatment of schizophrenia and related psychotic disorders, manic or mixed episodes in bipolar I disorder, and for use as an adjunct to antidepressants for…
Indication(s)Benzodiazepines are indicated in a treatment of a variety of disorders (depending on their pharmacokinetic profile and evidence), including anxiety disorder,…
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A Indication(s) OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Burpenorphine transdermal patch - butrans® and burprenorphine buccal soluble film belbuca®Indication(s)The management of pain severe enough to require daily, continuous, long…
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…
Indication(s)Compounded topical analgesics have not been approved by Health Canada and thus have no official indication for the topical treatment of pain.Formulary statusThe…
Corticosteroid injections in musculoskeletal conditions Indications/Clinical uses Treatment of acute and chronic musculoskeletal conditions including neck and upper…
Indication(s)Symptomatic relief of major depressive disorder (MDD).DAC recommendationThe Drug Advisory Committee (DAC) has recommended that desvenlafaxine not be listed on…
Indication (s)Treatment of symptoms associated with osteoarthritis of the knee (duration of treatment not to exceed 3 months).DAC recommendationThe Drug Advisory Committee (…
Indication(s)Symptomatic relief of major depressive disorder (MDD), generalized anxiety disorder (GAD), neuropathic pain associated with diabetic peripheral neuropathy (DPN…
Indication(s)Treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), and obsessive compulsive disorder (OCD).Formulary statusThe Drug Advisory…
Indication(s)Clinical management of occupational exposure to HIV.Formulary statusThe Drug Advisory Committee (DAC) recommended antiretroviral medications emtricitabine/…
Hypnotics: zopiclone, zolpidem, trazodone and tryptophanIndication(s)Zopiclone and sublingual zolpidem (oral disintegrating tablet, ODT- sublinox®): GABA agonists for short-…
Indication(s)The management of severe nausea and vomiting associated with cancer chemotherapy.Formulary statusThe Drug Advisory Committee (DAC) recommended that generic…
Indication(s)The relief of moderate to severe pain in adults who require continuous opioid analgesia for several days or more. The naloxone component is indicated for the…